|
| Press Releases |
|
 |
|
| Monday, February 24, 2020 |
|
|
Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and Signed Sales Distribution Agreement in Hong Kong |
| Aptorum Group Limited ("Aptorum Group"), a pharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the commercialization of its dietary supplement for women undergoing menopause and experiencing related symptoms. more info >> |
|
| Tuesday, February 11, 2020 |
|
|
Aptorum Group Announces Further Positive Data for its ALS-4 Small Molecule Anti-virulence (Non-bactericidal) Drug Candidate for Treatment of Infections caused by Staphylococcus Aureus |
| Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces further positive data from its current investigational new drug (IND)-enabling studies for ALS-4 more info >> |
|
| Monday, February 10, 2020 |
|
|
Aptorum Group Announces Significant Progress of Repurposed Drug Candidate, SACT-1 for Neuroblastoma Targeting IND Submission in H2 2020 |
| Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces positive data and development in relation to its repurposed drug candidate, SACT-1, for the treatment of neuroblastoma more info >> |
|
| Tuesday, September 10, 2019 |
|
|
Aptorum Group has initiated IND-Enabling Studies for its ALS-4 Small Molecule Candidate for the Treatment of Infections Caused by Staphylococcus Aureus including MRSA |
| Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces that it has initiated investigational new drug (IND)-enabling studies for ALS-4 more info >> |
|
|
Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug Candidates Targeting Neuroblastoma |
Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the development of two preclinical drug candidates which target obesity and neuroblastoma, respectively.
more info >> |
|
| Friday, December 7, 2018 |
|
|
Aptorum Group Limited Announces Pricing of Initial Public Offering |
| Aptorum Group Limited ("Aptorum", or the "Company"), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to tackle unmet medical needs, today announced that on December 3, 2018 more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
DASA, Latin America's Largest Diagnostic Provider, Selects AGFA HealthCare's Enterprise Imaging Platform in Flagship Agreement
Jul 1, 2025 16:00 HKT/SGT
|
|
|
JCB and Mandai Wildlife Group Deepen Partnership with exclusive discounts for JCB cardmembers 
Jul 1, 2025 16:00 JST
|
|
|
GFEAI 2025 Concludes Successfully: PM Paetongtarn Backs Human-Centric AI, AIGPC Emerges as Regional AI Ethics Hub
Jul 1, 2025 14:40 HKT/SGT
|
|
|
Fujitsu provides Japan's first AI-powered cloud-based library search service
Jul 1, 2025 11:30 JST
|
|
|
JCB Brings Apple Pay to Cardmembers in Vietnam
Jul 1, 2025 11:15 JST
|
|
|
First Shipment of LNG from the LNG Canada Project
Jul 1, 2025 11:00 JST
|
|
|
Chinabank Fully Transitions Into AI-powered Human Capital Management
Jul 1, 2025 08:00 HKT/SGT
|
|
|
HKIRA Announces Winners of the 11th IR Awards 2025
Jul 1, 2025 00:20 HKT/SGT
|
|
|
Approval in Principle (AiP) for World's First LCO2 / Methanol Carrier
Jun 30, 2025 20:30 JST
|
|
|
Acropolis Rally Greece: Day 4 Sunday success and second overall for TOYOTA GAZOO Racing's Ogier
Jun 30, 2025 20:15 JST
|
|
|
Mitsubishi Fuso-Hino Merger: 4 Firms Collaborate for the Future of Commercial Vehicles
Jun 30, 2025 20:10 JST
|
|
|
Six Companies Establish BlueRebirth Council to Expand Use of Recycled Materials in New Vehicles
Jun 30, 2025 19:25 JST
|
|
|
Honda Changes Plan to Build New Production Plant for Next-generation Fuel Cell Module in Japan
Jun 30, 2025 19:20 JST
|
|
|
MHI-AC&R Receives Recommendation Award of JARAC's 42nd Excellent Energy Saving Equipment Awards
Jun 30, 2025 19:00 JST
|
|
|
Eagle Football Holdings supports Leadership Changes at Olympique Lyonnais
Jun 30, 2025 15:30 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
